We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stem Cell and 3D Printing Generate Viable Tissue

By LabMedica International staff writers
Posted on 11 May 2017
Print article
Image: Three-dimensional (3D)-printed cartilage constructs growing in tissue culture (Photo courtesy of the University of Gothenburg).
Image: Three-dimensional (3D)-printed cartilage constructs growing in tissue culture (Photo courtesy of the University of Gothenburg).
A team of Swedish cell biologists combined three-dimensional (3D) bio-printing with advanced stem cell technology to create viable cultures of cartilage tissue that had cellular and mechanical properties similar to patients’ natural cartilage.

Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. To fill and cure such lesions, investigators at the University of Gothenburg developed a novel class of stem cells that could survive being injected by a three-dimensional printing method and then mature into functional cartilage tissue.

The investigators began with cartilage cells taken from patients undergoing knee surgery. These cells were then manipulated in a laboratory and transformed into induced pluripotent stem cells. The stem cells were expanded and encapsulated in a solution of nanofibrillated cellulose and printed into a structure using a three-dimensional (3D) bio-printer. Following printing, the stem cells were treated with growth factors that caused them to differentiate into cartilage tissue.

Much of the research effort involved finding a procedure to enable the cells to survive printing and multiply and a protocol that induced the cells to differentiate to form cartilage.

Results published in the April 6, 2017, online edition of the journal Scientific Reports revealed that pluripotency was initially maintained, and after five weeks, hyaline-like cartilaginous tissue with collagen type II expression and lacking tumorigenic Oct4 expression was observed in the three-dimensional (3D)-bio-printed constructs. Moreover, a marked increase in cell number within the cartilaginous tissue was detected by 2-photon fluorescence microscopy, indicating the importance of high cell densities in the pursuit of achieving good survival after printing.

“In nature, the differentiation of stem cells into cartilage is a simple process, but it is much more complicated to accomplish in a test tube. We are the first to succeed with it, and we did so without any animal testing whatsoever," said senior author Dr. Stina Simonsson, associate professor of cell biology at the University of Gothenburg. "We investigated various methods and combined different growth factors. Each individual stem cell is encased in nanocellulose, which allows it to survive the process of being printed into a three-dimensional (3D) structure. We also harvested media from other cells that contain the signals that stem cells use to communicate with each other - so called conditioned medium. In layman’s terms, our theory is that we managed to trick the cells into thinking that they are not alone.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more